SCHEMBL13584656

SCHEMBL13584656

N[C@@H](CCNC(=O)N1CCCCC1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.55
DPP7 Q9UHL4 4/20 0.45
LMNA P02545 1/20 0.42
CHRM1 P11229 2/20 0.40
ACE P12821 1/20 0.39
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GSR P00390 1/20 0.37
CYP1A2 P05177 1/20 0.37
GRIK1 P39086 1/20 0.37
GRM5 P41594 1/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
GRIA4 P48058 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13584659 1.00 EPHX2 (0.55) EPHX2DPP7LMNACHRM1ACE
SCHEMBL13585062 0.98 EPHX2 (0.56) EPHX2DPP7LMNACHRM1ACE
SCHEMBL13585063 0.98 EPHX2 (0.56) EPHX2DPP7LMNACHRM1ACE
SCHEMBL13585438 0.95 EPHX2 (0.53) EPHX2DPP7LMNACHRM1ACE
SCHEMBL13585441 0.95 EPHX2 (0.53) EPHX2DPP7LMNACHRM1ACE
SCHEMBL13585799 0.85 EPHX2 (0.45) EPHX2LMNACHRM1ACEALDH1A1
SCHEMBL1768811 0.85 HTT (0.48) EPHX2LMNAALDH1A1KMT2A
SCHEMBL13585795 0.85 EPHX2 (0.45) EPHX2LMNACHRM1ACEALDH1A1
SCHEMBL1768813 0.85 HTT (0.48) EPHX2LMNAALDH1A1KMT2A
SCHEMBL13585311 0.84 EPHX2 (0.42) EPHX2ACEGRM8GRM6GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754038-B2 Template-fixed peptidomimetics with CCR10 antagonistic activity POLYPHOR AG (CH) 2014-06-17 US disclosed
US-20120283168-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY POLYPHOR AG (CH) 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283168-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY CCR10, CCR1, CCRL2 EPHX2 1468/4885DPP7 1414/4885LMNA 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.